Current Issue

Mar.7, 2012

Vol. 112, No. 8

memorial

John Gary Curd ’67

Published in the Mar.7, 2012, issue

John Curd, a brilliant biotech leader, died peacefully April 20, 2011, in his home in Hillsborough, Calif.

John came to us from Wheat Ridge, Colo. A premed chemistry major, he was a member of Quad and roomed in Murray-Dodge with Peter Colt. After Harvard Medical School (and marriage to Karen Wendel) in 1971 and internship and residency at Mass General, John served at NIH and began a distinguished medical career.

John started in clinical practice and research at Scripps Clinic and Research Foundation, and later became hospital president. In 1991, he transitioned to biotechnology as vice president of clinical development at Genentech, where he discovered new cancer treatments and led the clinical development of Rituxan and the groundbreaking breast-cancer treatment Herceptin. He later served as executive vice president of VaxGen, president and chief medical officer of Novacea, and most recently president and chief medical officer of Threshold Pharmaceuticals. He was known for his brilliance as well as his kindness.

In addition to his passion for advancing science, John enjoyed spending time outdoors with his family, sharing a glass of wine with friends, and working on his cars.

John was a loving husband, inspiring father, and wonderful grandfather. He is survived by Karen, four children, and three grandchildren, to all of whom the class extends its condolences.

The Class of 1967


Note: The following is an expanded version of a memorial published in the March 7, 2012, issue of PAW.

John Curd died peacefully April 20, 2011, at his home in Hillsborough, Calif.

John came to Princeton from Wheat Ridge, Colo., where he was student body president. A premed chemistry major, he was a member of Quad and roomed in Murray Dodge with Peter Colt. After graduation from Harvard Medical School (and marriage to Karen Wendel) in 1971, and an internship and residency at Mass General, John served as a lieutenant commander in the Navy at NIH. In 1975, he and Karen moved to California.

John will be remembered for his contributions and life service to the medical profession. He dedicated the first 16 years of his medical career to clinical practice and research in rheumatology at Scripps Clinic and Research Foundation, where he served as president of the Scripps Green Hospital. In 1991, he transitioned to biotechnology as the vice president of clinical development at Genentech, where he concentrated for 10 years on discovering new cancer treatments and led the clinical development of Rituxan and the groundbreaking breast cancer treatment Herceptin. He then served as executive vice president of VaxGen, president and chief medical officer of Novacea, and most recently president and chief medical officer of Threshold Pharmaceuticals. John also served on the boards of several start-up biotechnology companies.

In addition to his passion for advancing science and medicine, John enjoyed spending time outdoors. He camped and backpacked with his family in Yosemite, Alaska, and the Grand Canyon. John also enjoyed sharing a glass of wine with friends and working on his cars.See http://1000memories.com/johncurd/memories.

John was as a loving husband, inspiring father, and wonderful grandfather. He is survived by Karen; his four children, Alison (Tyson) Lowery, Jonathan (Jessica) Curd, Edward Curd, and Bethany Curd; and three grandchildren, Jackson and Kensington Curd and Calista Lowery, to all of whom the class extends its condolences.

Post a remembrance
Post a remembrance
John Gary Curd
Enter the word as it appears in the picture below
Send
By submitting a comment, you agree to PAW's comment posting policy.
CURRENT ISSUE: Mar.7, 2012

Memorials Search:

Search:
mudd archive memorials
PAW's online memorial repository currently contains the full text of all memorials published since 1989. To find a memorial published in PAW before this time period, please check the Mudd Library Archives.
no space